Search Results1-15 of  15

  • YURI Masatoshi ID: 9000005190774

    Department of Chemistry, Tokyo Institute of Technology (1995 from CiNii)

    Articles in CiNii:3

    • Non-stereoselective Formation of 3α, 7α, 12α, 24-Tetrahydroxy-5β-cholestan-26-oic Acid during Cholic Acid Biosynthesis (1994)
    • NON-STEREOSPECIFIC FORMATION OF 3α, 7α, 24-TRIHYDROXY-5β-CHOLESTAN-26-OIC ACID DURING CHENODEOXYCHOLIC ACID BIOSYNTHESIS (1994)
    • 32 Stereochemical Aspects of Steroidal Side Chain Cleavage (β-Oxidation) during Cholic Acid Biosynthesis (1995)
  • YURI Masatoshi ID: 9000254238515

    Articles in CiNii:1

    • Non-stereoselective Formation of 3.ALPHA.,7.ALPHA.,12.ALPHA.,24-Tetrahydroxy-5.BETA.-cholestan- 26-oic Acid during Cholic Acid Biosynthesis. (1994)
  • YURI Masatoshi ID: 9000254238890

    Articles in CiNii:1

    • Non-stereospecific Formation of 3.ALPHA.,7.ALPHA.,24-Trihydroxy-5.BETA.-cholestan-26-oic Acid during Chenodeoxycholic Acid Biosynthesis. (1994)
  • YURI Masatoshi ID: 9000254708094

    Articles in CiNii:1

    • Identification of 27-Nor-3.ALPHA.,7.ALPHA.,12.ALPHA.-trihydroxycoprostan-24-one Apparently Derived from 3.ALPHA.,7.ALPHA.,12.ALPHA.-Trihydroxy-24-oxocoprostanoic Acid, a Postulated Intermediate of Bile Acid Biosynthesis. (1993)
  • YURI Masatoshi ID: 9000258713116

    Molecular Medicine Research Labs., Astellas Pharma Inc. (2013 from CiNii)

    Articles in CiNii:1

    • Identification of novel biomarkers for drug-induced renal papillary necrosis in rats by toxicoproteomics (2013)
  • YURI Masatoshi ID: 9000283730336

    Analysis & Pharmacokinetics Research Labs., Astellas Pharma Inc. (2012 from CiNii)

    Articles in CiNii:1

    • Toxicoproteomic and toxicogenomic approaches: Identification and verification of novel biomarkers for renal papillary necrosis in rats (2012)
  • YURI Masatoshi ID: 9000283732791

    Analysis & Pharmacokinetics Research Labs., Astellas Pharma Inc., Japan (2012 from CiNii)

    Articles in CiNii:1

    • Identification and verification of novel biomarkers for drug-induced renal papillary necrosis in rats using toxicoproteomic and toxicogenomic approaches (2012)
  • Yuri Masatoshi ID: 9000006705689

    Sumitomo Pharmaceuticals Research Center (1996 from CiNii)

    Articles in CiNii:1

    • 25 A Convenient and Efficient Synthesis of Sialyl LeX Analogs (1996)
  • Yuri Masatoshi ID: 9000347091598

    Astellas Pharma Inc. (2011 from CiNii)

    Articles in CiNii:1

    • Identification and relative quantitation of an orphan G-protein coupled receptor SREB2 (GPR85) protein in mouse brain using a linear ion trap mass spectrometer (2011)
  • Yuri Masatoshi ID: 9000347092402

    Astellas Pharma Inc. , Drug Discovery Research, Proteomics Research Team (2011 from CiNii)

    Articles in CiNii:1

    • Application of proteomics for drug discovery research (2011)
  • Yuri Masatoshi ID: 9000391970952

    Drug Discovery Research, Astellas Pharm Inc. (2007 from CiNii)

    Articles in CiNii:1

    • alpha1-Microglobulin as a Urinary Marker of IgA Nephropathy (2007)
  • Yuri Masatoshi ID: 9000391972941

    Analysis and Pharmacokinetics Research labs., Astellas Pharma Inc. (2006 from CiNii)

    Articles in CiNii:1

    • Neutrophil elastase is a potential urinary diagnosis marker for interstitial cystitis (2006)
  • Yuri Masatoshi ID: 9000391976227

    Astellas Pharma Inc. (2009 from CiNii)

    Articles in CiNii:1

    • Combination of MS protein identification and bioassay of chromatographic fractions to identify biologically active substances from complex protein sources (2009)
  • Yuri Masatoshi ID: 9000392143009

    Bioscience Research Labs, Astellas Pharma Inc. (2017 from CiNii)

    Articles in CiNii:1

    • Urinary proteome profile of renal papillary necrosis in experimental model rats (2017)
  • yuri masatoshi ID: 9000347092555

    アステラス製薬株式会社 (2012 from CiNii)

    Articles in CiNii:1

    • YM155 suppresses survivin expression by disrupting the ILF3/p54<sup>nrb</sup> transcription factor complex (2012)
Page Top